BioNTech
phase favorable safety profile biologic activity and early activity observed with further evaluation i tar achieved disease control | BioNTech
Company
Deck Type
Deck date
November 2021
Slide
29 of 40
Related slides by other companies
Investor Presentation
December 2023
Investor Day
September 2022
Results
November 2024
Investor Presentation
October 2023
Other recent decks by BioNTech
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies